首页> 美国卫生研究院文献>other >NEW DEVELOPMENTS IN THE DIAGNOSIS AND TREATMENT OF THYROID CANCER
【2h】

NEW DEVELOPMENTS IN THE DIAGNOSIS AND TREATMENT OF THYROID CANCER

机译:甲状腺癌诊断与治疗的新进展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Thyroid cancer exists in several forms. Differentiated thyroid cancers include papillary and follicular histologies. These tumors exist along a spectrum of differentiation, and their incidence continues to climb. A number of advances in the diagnosis and treatment of differentiated thyroid cancers now exist. These include molecular diagnostics and more advanced strategies for risk stratification. Medullary cancer arises from the parafollicular cells and not the follicular cells. Therefore, diagnosis and treatment differs from differentiated thyroid tumors. Genetic testing and newer adjuvant therapies has changed the diagnosis and treatment of medullary thyroid cancer. This review will focus on the epidemiology, diagnosis, work-up, and treatment of both differentiated and medullary thyroid cancers, focusing specifically on newer developments in the field.
机译:甲状腺癌以几种形式存在。分化型甲状腺癌包括乳头状和滤泡性组织学。这些肿瘤沿分化谱存在,并且其发病率持续攀升。现在,在分化型甲状腺癌的诊断和治疗中存在许多进展。这些措施包括分子诊断和更高级的风险分层策略。髓样癌起源于滤泡旁细胞而不是滤泡细胞。因此,诊断和治疗不同于分化的甲状腺肿瘤。基因检测和更新的辅助疗法改变了甲状腺髓样癌的诊断和治疗。这篇综述将侧重于分化型甲状腺髓样癌和甲状腺髓样癌的流行病学,诊断,检查和治疗,尤其是该领域的新进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号